TABLE 1.

Patient Characteristics and Univariate Chi-Square Analysis for Predictors of Receiving Prostate Brachytherapy

Characteristic	Patients Not Receiving Brachytherapy	Patients Receiving Brachytherapy	Chi-Square P
Risk group			<.0001
Low	77.8%	22.2%
Intermediate	84.7%	15.3%
High	90.6%	9.4%
Race			<.0001
White	83.2%	16.8%
African American	82.8%	17.2%
Ethnicity			<.0001
Hispanic	87.5%	12.5%
Non-Hispanic	82.9%	15.3%
Age, y			<.0001
<50	92.5%	7.5%
51–60	87.5%	12.5%
61–70	82.2%	17.8%
≥71	80.5%	19.5%
Charlson/Deyo comorbidity index			<.0001
0	82.8%	17.2%
1	85.3%	14.7%
2	88.4%	11.6%
Facility type			<.0001
Community cancer program	82.7%	17.3%
Comprehensive community cancer program	80.5%	19.5%
Academic/research program	87.2%	12.8%
Other	86.6%	13.4%
Insurance			<.0001
Private/HMO	85.2%	14.8%
Medicaid	88.1%	11.9%
Medicare	80.4%	19.6%
None/other/unknown	85.7%	14.3%
Urban setting			<.0001
Large metropolitan	82.9%	17.1%
Small metropolitan	84.2%	15.8%
Suburban	81.4%	18.6%
Rural	84.0%	16.0%
Median income quartile			.0012
<$30,000	83.2%	16.8%
$30,000–$35,000	83.0%	17.0%
$35,000–$45,999	83.3%	16.7%
>$46,000	83.4%	16.6%
% in region without high school diploma			<.0001
>29%	83.5%	16.5%
20%–28.9%	82.5%	17.5%
14%–19.9%	82.8%	17.2%
<14%	83.9%	16.1%
Region			<.0001
Northeast (CT, MA, ME, NH, RI, and VT)	85.4%	14.6%
Atlantic (NJ, NY, and PA)	81.3%	18.7%
Southeast (DC, DE, FL, GA, MD, NC, SC, VA, and WV)	77.9%	22.1%
Great Lakes (IL, IN, MI, OH, and WI)	83.9%	16.1%
South (AL, KY, MS, and TN)	84.7%	15.3%
Midwest (IA, KS, MN, MO, ND, NE, and SD)	87.0%	13.0%
West (AR, LA, OK, and TX)	88.4%	11.6%
Mountain (AZ, CO, ID, MT, NM, NV, UT, and WY)	86.1%	13.9%
Pacific (AK, CA, HI, OR, and WA)	85.9%	14.1%

Abbreviation: HMO, health maintenance organization.